QIAGEN N.V. (QGEN) Stock Price & Overview
NYSE:QGEN • NL0015002SN0
The current stock price of QGEN is 46.44 USD. Today QGEN is down by -0.94%. In the past month the price decreased by -10.19%. In the past year, price increased by 10.99%.
QGEN Key Statistics
- Market Cap
- 9.567B
- P/E
- 18.80
- Fwd P/E
- 17.24
- EPS (TTM)
- 2.47
- Dividend Yield
- 0.54%
QGEN Stock Performance
QGEN Stock Chart
QGEN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to QGEN. When comparing the yearly performance of all stocks, QGEN turns out to be only a medium performer in the overall market: it outperformed 46.73% of all stocks.
QGEN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to QGEN. QGEN has an excellent profitability rating, but there are some minor concerns on its financial health.
QGEN Earnings
On February 5, 2026 QGEN reported an EPS of 0.62 and a revenue of 540.42M. The company missed EPS expectations (-3.03% surprise) and missed revenue expectations (-0.31% surprise).
QGEN Forecast & Estimates
24 analysts have analysed QGEN and the average price target is 55.35 USD. This implies a price increase of 19.19% is expected in the next year compared to the current price of 46.44.
For the next year, analysts expect an EPS growth of 8.94% and a revenue growth 6.51% for QGEN
QGEN Groups
Sector & Classification
QGEN Financial Highlights
Over the last trailing twelve months QGEN reported a non-GAAP Earnings per Share(EPS) of 2.47. The EPS increased by 10.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.33% | ||
| ROA | 6.75% | ||
| ROE | 11.25% | ||
| Debt/Equity | 0.44 |
QGEN Ownership
QGEN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 20.9 | 192.623B | ||
| DHR | DANAHER CORP | 23.78 | 144.724B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 140.48 | 46.68B | ||
| A | AGILENT TECHNOLOGIES INC | 17.65 | 34.077B | ||
| IQV | IQVIA HOLDINGS INC | 13.64 | 30.168B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.28 | 26.158B | ||
| ILMN | ILLUMINA INC | 24.77 | 19.707B | ||
| WAT | WATERS CORP | 21.81 | 18.993B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.13 | 17.902B | ||
| MEDP | MEDPACE HOLDINGS INC | 27.92 | 13.123B | ||
| RVTY | REVVITY INC | 17.56 | 11.167B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 9.169B | ||
| TECH | BIO-TECHNE CORP | 24.89 | 9.051B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About QGEN
Company Profile
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 5,654 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Company Info
QIAGEN N.V.
Hulsterweg 82
Venlo LIMBURG 5912 NL
CEO: Thierry Bernard
Employees: 5654
Phone: 31773556600
QIAGEN N.V. / QGEN FAQ
Can you describe the business of QIAGEN N.V.?
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 5,654 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Can you provide the latest stock price for QIAGEN N.V.?
The current stock price of QGEN is 46.44 USD. The price decreased by -0.94% in the last trading session.
Does QGEN stock pay dividends?
QIAGEN N.V. (QGEN) has a dividend yield of 0.54%. The yearly dividend amount is currently 0.
What is the ChartMill technical and fundamental rating of QGEN stock?
QGEN has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Should I buy QGEN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on QGEN.
Can you provide the number of employees for QIAGEN N.V.?
QIAGEN N.V. (QGEN) currently has 5654 employees.
Can you provide the upcoming earnings date for QIAGEN N.V.?
QIAGEN N.V. (QGEN) will report earnings on 2026-05-05, after the market close.